Literature DB >> 16214322

Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.

Suleyman S Hacievliyagil1, Hakan Gunen, Levent C Mutlu, Aysun B Karabulut, Ismail Temel.   

Abstract

Cytokines are known to be increased in induced sputum in chronic obstructive pulmonary disease (COPD). In this study, the relationship between the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumour necrosis factor-alpha (TNF-alpha) in induced sputum of patients with exacerbation of COPD, and the severity of the disease, pulmonary function tests (PFT), arterial blood gases (ABG) were studied. Twenty-four patients with exacerbation of COPD were included in the study. The patients were grouped according to their PFT into two as: Group 1 (FEV1 below 50% of the predicted value, severe-very severe COPD, n=12) and, Group 2 (FEV1 above 50% of the predicted value, mild-moderate COPD, n=12). The levels of IL-6, IL-8 and TNF-alpha in induced sputum of the subjects were measured. The mean levels of IL-6, IL-8 and TNF-alpha in induced sputum were found to be higher in Group 1 (severe-very severe COPD) than in Group 2 (mild-moderate COPD). The differences in IL-6 and IL-8 levels between groups were statistically significant (P<0.05). A significant correlation was observed between the IL-6 value and FEV(1) (r=-0.435, P=0.034), FEV1/FVC (r=-0.446, P=0.029), PaO2 (r=-0.711, P=0.000), SaO2 (r=-0.444, P=0.030) and disease duration (r=0.427, P=0.037), respectively. Also, the level of IL-8 in induced sputum was inversely correlated with FEV1 (r=-0.562, P=0.004), PaO2 (r=-0.540, P=0.006) and SaO2 (r=-0.435, P=0.034). However, all three cytokines were positively correlated with the smoking load (r=0.653, P=0.001; r=0.439, P=0.032; r=0.649, P=0.001). We conclude, therefore, that in exacerbated COPD cases with greater degrees of obstruction of the airways have higher levels of cytokines in induced sputum. This can be interpreted to mean that these cytokines are related to the clinical parameters like the ABG and PFT and seem to be the determinant of the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214322     DOI: 10.1016/j.rmed.2005.08.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  32 in total

1.  Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.

Authors:  Seiko Susuki-Miyata; Masanori Miyata; Byung-Cheol Lee; Haidong Xu; Hirofumi Kai; Chen Yan; Jian-Dong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 2.  Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 3.  p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD.

Authors:  Audreesh Banerjee; Cynthia Koziol-White; Reynold Panettieri
Journal:  Curr Opin Pharmacol       Date:  2012-02-24       Impact factor: 5.547

4.  Grape seed proanthocyanidin extract inhibits interleukin-17-induced interleukin-6 production via MAPK pathway in human pulmonary epithelial cells.

Authors:  Hyeongseok Kim; Jin Young Kim; Hong Suk Song; Keon Uk Park; Kyo-Chul Mun; Eunyoung Ha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-12       Impact factor: 3.000

5.  Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust.

Authors:  Tara M Nordgren; Christopher D Bauer; Art J Heires; Jill A Poole; Todd A Wyatt; William W West; Debra J Romberger
Journal:  Transl Res       Date:  2015-01-13       Impact factor: 7.012

6.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

7.  Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.

Authors:  Gregory H Taylor; Adrienne A Williams; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

8.  Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.

Authors:  Wendy A Neveu; Jenna L Allard; Danielle M Raymond; Lorraine M Bourassa; Stephanie M Burns; Janice Y Bunn; Charles G Irvin; David A Kaminsky; Mercedes Rincon
Journal:  Respir Res       Date:  2010-03-08

Review 9.  Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

10.  Lower airway disease in asthmatics with and without rhinitis.

Authors:  Anne E Dixon; Danielle M Raymond; Benjamin T Suratt; Lorraine M Bourassa; Charles G Irvin
Journal:  Lung       Date:  2008-10-09       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.